Meanwhile, it is suggested that miR‐384 inhibits the tumorigenesis of renal cancer through regulating cyclin‐dependent kinase 6,30 which supports our finding that miR‐384 suppresses bladder cancer cell viability. This evidence concerns the gene CDK6 and urinary bladder cancer.